Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes

NCT ID: NCT01382459

Last Updated: 2011-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators assume that an intervention program that includes home visits and trainings of diabetes' nurse and dietitian will lead to an improvement of the patients' metabolic balance, a decrease in complications' rate, a reduction of hospitalizations and an economic streamlining.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators assume that during the study, subjects from the intervention group will reach a better metabolic balance than the control group. In this group the following changes will occur:

* A decrease in HbA1C levels.
* A decrease in Hypoglycemia events.
* A decrease in DKA events.
* A decrease in patients' visits in ER and hospitalizations.
* An improvement in the knowledge of the patients and their families about the disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

type 1 DM children- intervention group

will have home visits and trainings at school

No interventions assigned to this group

type 1 DM children- control group

will receive the standard care at the clinic

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 1 DM diagnosis from at least 8 months/
* HbA1C levels \>8
* Signed inform consent.

Exclusion Criteria

\- Children who are not in educational settings and are not hebrew or arabic speakers.
Minimum Eligible Age

4 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clalit Health Services

OTHER

Sponsor Role collaborator

Soroka University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pediatric endocrinology and diabetes unit

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Soroka medical center

Beersheba, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eli Hershkovitz, PI

Role: CONTACT

972- 522629025

Addi Maabari, S.C

Role: CONTACT

972-547280902

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eli Hershkovitz, PI

Role: primary

972-522629025

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sor517111ctil

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetes Transition Coordinator Study
NCT06300047 ENROLLING_BY_INVITATION NA